🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparative randomized, single dose, three way three sequence two treatment...
Status
Completed
Location
Genuine Research Center GRC
Start Date
2016-05
Trial ID
NCT02953535
Treatments Being Tested
The objective of the study is to compare the pharmacokinetic profile of ril...
Status
Completed
Location
CROSS Research SA Phase 1 Unit
Start Date
2021-01-15
Trial ID
NCT04819438
Treatments Being Tested
The purpose of The Quatro Study is to assess the acceptability, preferences...
Status
Completed
Location
MatCH Research
Start Date
2016-06-06
Trial ID
NCT02602366
Treatments Being Tested
The study will investigate whether administration of clazosentan can affect...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2018-09-18
Trial ID
NCT03657446
Treatments Being Tested
The main objective of this trail is to investigate if and to what extent BI...
Status
Completed
Location
Collaborative Neuroscience Research, LLC
Start Date
2020-12-01
Trial ID
NCT04602221
Treatments Being Tested
The main objective of this trial is to establish the bioequivalence of zong...
Status
Completed
Location
CRS Clinical Research Services Mannheim GmbH
Start Date
2024-04-30
Trial ID
NCT06360081
Treatments Being Tested
The main objective of this trial is to evaluate the effects of a single the...
Status
Completed
Location
Quotient Sciences
Start Date
2024-03-06
Trial ID
NCT06107036
Treatments Being Tested
This was a randomized controlled pilot trial to evaluate clinical efficacy ...
Status
Completed
Location
University of California San Francisco
Start Date
2010-05
Trial ID
NCT01210651
Treatments Being Tested
This study will investigate the potential drug interactions between vemirco...
Status
Completed
Location
Research Site
Start Date
2024-01-17
Trial ID
NCT06071442
Treatments Being Tested
To examine the effect of the strong CYP3A4/5 inhibitor itraconazole (200 mg...
Status
Completed
Location
FR801
Start Date
2014-03
Trial ID
NCT02122692
Treatments Being Tested